Literature DB >> 11774398

Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis.

Alessandro Franchi1, Oreste Gallo, Milena Paglierani, Iacopo Sardi, Lucia Magnelli, Emanuela Masini, Marco Santucci.   

Abstract

BACKGROUND: The nitric oxide (NO) pathway plays a relevant role in angiogenesis and tumor progression in squamous cell carcinoma (SCC) of the head and neck. The aim of this study was to assess whether the NO pathway may be correlated with angiogenesis in the transition from laryngeal dysplasia to invasive carcinoma.
METHODS: We investigated the expression of the inducible NO synthase (iNOS) in 26 laryngeal precancerous lesions and 35 squamous cell carcinomas with respect to microvessel density. In addition, we determined iNOS activity and cGMP levels in specimens from SCCs.
RESULTS: There was a significant increase of iNOS levels detected immunohistochemically passing from hyperplastic/mild dysplastic to moderate/severe dysplastic lesions to SCC (p =.04). Accordingly, Northern and Western analyses demonstrated higher iNOS mRNA and protein levels in SCCs than dysplastic mucosa. iNOS expression was significantly correlated with microvessel counts both in the group of preneoplastic lesions (p =.02) and in the group of SCCs (p =.01). In addition, iNOS activity was correlated with iNOS immunohistochemical expression (p =.1) and was significantly associated with increased vascularization (p =.03) in SCCs. Similarly, iNOS expression was significantly correlated with cGMP levels in SCC (p =.02) and increased tumor vascularization correlated with higher cGMP levels (rs =.4; p =.01).
CONCLUSIONS: Our data indicate that the NO pathway may play a relevant role in the angiogenesis associated with the progression from laryngeal dysplasia to laryngeal SCC. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774398     DOI: 10.1002/hed.10045

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Effect of camptothecin on inducible nitric oxide synthase expression in the colon cancer SW480 cell line.

Authors:  Xiangdi Shen; Jian Chen; Rong Qiu; Xingli Fan; Ying Xin
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

2.  Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.

Authors:  Fabio Cianchi; Camillo Cortesini; Ornella Fantappiè; Luca Messerini; Nicola Schiavone; Alfredo Vannacci; Silvia Nistri; Iacopo Sardi; Gianna Baroni; Cosimo Marzocca; Federico Perna; Roberto Mazzanti; Paolo Bechi; Emanuela Masini
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ling Li; Bing-Zhong Sun; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Relation between Endothelial Nitric Oxide Synthase Genotypes and Oxidative Stress Markers in Larynx Cancer.

Authors:  K Yanar; U Çakatay; S Aydın; A Verim; P Atukeren; N E Özkan; K Karatoprak; T Cebe; S Turan; E Ozkök; G Korkmaz; C Cacına; O Küçükhüseyin; İ Yaylım
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

5.  Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas.

Authors:  Gamze Erkılınç; Hasan Yasan; Yusuf Çağdaş Kumbul; Mehmet Emre Sivrice; Meltem Durgun
Journal:  J Pathol Transl Med       Date:  2022-05-03

6.  Molecular docking studies of quercetin and its analogues against human inducible nitric oxide synthase.

Authors:  Salam Pradeep Singh; Bolin Kumar Konwar
Journal:  Springerplus       Date:  2012-12-17

7.  Macrophage-tumor cell interactions regulate the function of nitric oxide.

Authors:  Michal A Rahat; Bernhard Hemmerlein
Journal:  Front Physiol       Date:  2013-06-18       Impact factor: 4.566

Review 8.  Angiogenesis in pre-malignant conditions.

Authors:  S R Menakuru; N J Brown; C A Staton; M W R Reed
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.